Human endogenous retroviruses and cancer prevention: evidence and prospects
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cancer is a significant and growing problem worldwide. While this increase may, in part, be attributed to increasing longevity, improved case notifications and risk-enhancing lifestyle (such as smoking, diet and obesity), hygiene-related factors resulting in immuno-regulatory failure may also play a major role and call for a revision of vaccination strategies to protect against a range of cancers in addition to infections. DISCUSSION: Human endogenous retroviruses (HERVs) are a significant component of a wider family of retroelements that constitutes part of the human genome. They were originated by the integration of exogenous retroviruses into the human genome millions of years ago. HERVs are estimated to comprise about 8% of human DNA and are ubiquitous in somatic and germinal tissues.Physiologic and pathologic processes are influenced by some biologically active HERV families. HERV antigens are only expressed at low levels by the host, but in circumstances of inappropriate control their genes may initiate or maintain pathological processes. Although the precise mechanism leading to abnormal HERVs gene expression has yet to be clearly elucidated, environmental factors seem to be involved by influencing the human immune system.HERV-K expression has been detected in different types of tumors.Among the various human endogenous retroviral families, the K series was the latest acquired by the human species. Probably because of its relatively recent origin, the HERV-K is the most complete and biologically active family.The abnormal expression of HERV-K seemingly triggers pathological processes leading to melanoma onset, but also contributes to the morphological and functional cellular modifications implicated in melanoma maintenance and progression.The HERV-K-MEL antigen is encoded by a pseudo-gene incorporated in the HERV-K env-gene. HERV-K-MEL is significantly expressed in the majority of dysplastic and normal naevi, as well as other tumors like sarcoma, lymphoma, bladder and breast cancer. An amino acid sequence similar to HERV-K-MEL, recognized to cause a significant protective effect against melanoma, is shared by the antigenic determinants expressed by some vaccines such as BCG, vaccinia virus and the yellow fever virus.HERV-K are also reactivated in the majority of human breast cancers. Monoclonal and single-chain antibodies against the HERV-K Env protein recently proved capable of blocking the proliferation of human breast cancer cells in vitro, inhibiting tumor growth in mice bearing xenograft tumors. SUMMARY: A recent epidemiological study provided provisional evidence of how melanoma risk could possibly be reduced if the yellow fever virus vaccine (YFV) were received at least 10 years before, possibly preventing tumor initiation rather than culling melanoma cells already compromised. Further research is recommended to confirm the temporal pattern of this protection and eliminate/attenuate the potential role of relevant confounders as socio-economic status and other vaccinations.It appears also appropriate to examine the potential protective effect of YFV against other malignancies expressing high levels of HERV-K antigens, namely breast cancer, sarcoma, lymphoma and bladder cancer.Tumor immune-therapy, as described for the monoclonal antibodies against breast cancer, is indeed considered more complex and less advantageous than immune-prevention. Cellular immunity possibly triggered by vaccines as for YFV might also be involved in anti-cancer response, in addition to humoral immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Causal Diagrams for Epidemiologic Research
Greenland, S., Pearl, J., & Robins, J. M. (1999) · Epidemiology · doi:10.1097/00001648-199901000-00008 · Cited by 3,728
Mobile Elements: Drivers of Genome Evolution
Kazazian, H. H. (2004) · Science · doi:10.1126/science.1089670 · Cited by 1,922 · cited 1×
“Approximately 45% of human genome is actually composed of or derived from virus-like transposon-related elements [11,12].”
BackgroundEpidemiology and Prevention of Breast Cancer
Kelsey, J. L., & Bernstein, L. (1996) · Annual Review of Public Health · doi:10.1146/annurev.pu.17.050196.000403 · Cited by 376
A global view on the development of non communicable diseases
Wagner, K.-H., & Brath, H. (2012) · Preventive Medicine · doi:10.1016/j.ypmed.2011.11.012 · Cited by 362
Studies of endogenous retroviruses reveal a continuing evolutionary saga
Stoye, J. P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2783 · Cited by 350
Tristem, M. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3715-3730.2000 · Cited by 330 · cited 1×
“HERVs are classified in more than 22 different families [15,41-44] depending on their sequence identity and partly on the similarity of their primer binding sites to host tRNAs [15,44,45].”
BackgroundEndogenous retroviruses in the human genome sequence.
(2001) · Genome biology · doi:10.1186/gb-2001-2-6-reviews1017 · Cited by 317 · cited 1×
“Approximately 45% of human genome is actually composed of or derived from virus-like transposon-related elements [11,12].”
BackgroundIdentification of human endogenous retroviruses with complex mRNA expression and particle formation.
Löwer, R., Boller, K., Hasenmaier, B., Korbmacher, C., Müller-Lantzsch, N., Löwer, J., & Kurth, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4480 · Cited by 268 · cited 1×
“HERV-K is the only known retroviral family that has retained functional full-length open reading frames (ORF) coding for structural and enzymatic proteins [15,49,50] and appears capable to induce the generation of replicating viral components [29,47,51].”
BackgroundExpression of Human Endogenous Retrovirus K in Melanomas and Melanoma Cell Lines
Büscher, K., Trefzer, U., Hofmann, M., Sterry, W., Kurth, R., & Denner, J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2983 · Cited by 249 · cited 5×
“Transcripts of HERVs have been detected by many independent investigators in different tumors: breast cancer [25,54-60], ovarian cancer [61], lymphoma [54], melanoma [25,62,63], germ line tumors [51,60,64], haematological neoplasms [65,66], sarcoma [25],”
BackgroundInfluentialHuman endogenous retrovirus HERV-K113 is capable of producing intact viral particles
Boller, K., Schönfeld, K., Lischer, S., Fischer, N., Hoffmann, A., Kurth, R., & Tönjes, R. R. (2008) · Journal of General Virology · doi:10.1099/vir.0.83534-0 · Cited by 138
Cited by
Classification and characterization of human endogenous retroviruses; mosaic forms are common
Vargiu, L., Rodriguez-Tomé, P., Sperber, G. O., Cadeddu, M., Grandi, N., Blikstad, V., Tramontano, E., & Blomberg, J. (2016) · Retrovirology · doi:10.1186/s12977-015-0232-y · Cited by 315
Hohn, O., Hanke, K., & Bannert, N. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00246 · Cited by 196
Human endogenous retroviruses and cancer
María, G.-C., Paola, I., Niki, K., Mariacarmela, S., Julià, B., & Rafael, R. (2016) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2016.0080 · Cited by 100
Metadata
- Authors
- Cegolon, L., Salata, C., Weiderpass, E., Vineis, P., Palù, G., & Mastrangelo, G.
- Venue
- BMC Cancer
- Published
- 2013-01-03
- Volume
- 13
- Issue
- 1
- Pages
- 4-4
- ISSN
- 1471-2407 (ISSN-L)
- OpenAlex
- W2163581514
- Cited by
- 77
- References
- 11
- FWCI
- 10.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human endogenous retroviruses and cancer prevention: evidence and prospects. https://app.cochat.ai/papers/10.1186/1471-2407-13-4
- The paper
- Cegolon, L., Salata, C., Weiderpass, E., Vineis, P., Palù, G., & Mastrangelo, G. (2013). Human endogenous retroviruses and cancer prevention: evidence and prospects. BMC Cancer. https://doi.org/10.1186/1471-2407-13-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.